Chemo w/ Anthracycline Better Than w/o for Early, HER2-Neg

Moderators

Chemo Regimen With Anthracycline Better Than Regimen Without for Early-Stage, HER2-Negative Disease With High Risk of Recurrence
April 12, 2017
An analysis of several studies found that chemotherapy regimens that include an anthracycline are better than a regimen that doesn't include an anthracycline for women diagnosed with early-stage, HER2-negative breast cancer with a high risk of recurrence. Read more...